Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endotheliumBo Lu, Ling Geng, Amy Musiek, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerRobert Timmerman, James Galvin, Jeff Michalski, et al.
Clinical Lung Cancer|February 20, 2008
Cooperative group research efforts in lung cancer: focus on early-stage non-small-cell lung cancerHeather Wakelee, Corey Langer, Everett Vokes, et al.
JAMA Oncology|March 15, 2019
Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical TrialAlexander Sun, Chen Hu, Stuart J Wong, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2015
Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studiesHak Choy, David E Gerber, Jeffrey D Bradley, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2010
A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515Jeffrey Bradley, Kyounghwa Bae, Noah Choi, et al.
Journal of Radiation Oncology|December 19, 2018
An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential ChemoradiotherapyAndre Konski, Mytheryi Bhargavan, Jean Owen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Defining local-regional control and its importance in locally advanced non-small cell lung carcinomaMitchell Machtay, Rebecca Paulus, Jennifer Moughan, et al.
Clinical Lung Cancer|August 16, 2005
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534Wallace Akerley, James E Herndon, Alan P Lyss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2013
A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92Carlos R Becerra, Nasser Hanna, Andrew David McCollum, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endotheliumBo Lu, Ling Geng, Amy Musiek, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerRobert Timmerman, James Galvin, Jeff Michalski, et al.
Clinical Lung Cancer|February 20, 2008
Cooperative group research efforts in lung cancer: focus on early-stage non-small-cell lung cancerHeather Wakelee, Corey Langer, Everett Vokes, et al.
JAMA Oncology|March 15, 2019
Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical TrialAlexander Sun, Chen Hu, Stuart J Wong, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2015
Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studiesHak Choy, David E Gerber, Jeffrey D Bradley, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2010
A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515Jeffrey Bradley, Kyounghwa Bae, Noah Choi, et al.
Journal of Radiation Oncology|December 19, 2018
An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential ChemoradiotherapyAndre Konski, Mytheryi Bhargavan, Jean Owen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Defining local-regional control and its importance in locally advanced non-small cell lung carcinomaMitchell Machtay, Rebecca Paulus, Jennifer Moughan, et al.
Clinical Lung Cancer|August 16, 2005
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534Wallace Akerley, James E Herndon, Alan P Lyss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2013
A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92Carlos R Becerra, Nasser Hanna, Andrew David McCollum, et al.
Pageof 14